| FA158666 |
59-53-0 |
N-Acetyl-DL-penicillamine |
|
Protective agent against mercuric chloride poisoning |
|
| FA01736 |
90058-29-0 |
Alaptide |
|
Nootropic agent; affects dopaminergic system |
|
| FA17279 |
26750-81-2 |
Alibendol |
|
Anti-spasmodic, choleretic and cholekinetic agent |
|
| FA17334 |
645-05-6 |
Altretamine |
|
Alkylating agent; cytotoxic; antineoplastic |
|
| FA17353 |
20537-88-6 |
Amifostine |
|
Radio- and chemoprotective agent |
|
| W-105849 |
521-17-5 |
5-Androstenediol |
|
|
|
| FA73663 |
113-80-4 |
[Arg8]-Vasotocin trifluoroacetate |
|
|
|
| FA17994 |
88495-63-0 |
Artesunate |
|
Prodrug of dihydroartemisin (DHA); antimalarial |
|
| FB18131 |
80573-04-2 |
Balsalazide |
|
Prodrug of 5-aminosalicylic acid; anti-inflammatory |
BIO-X |
| FB18146 |
138356-09-9 |
BD 1008 dihydrobromide |
|
Sigma (σ) receptor antagonist |
BIO-X |
| FB18147 |
150208-28-9 |
BD 1063 |
|
Antagonist of σ1 receptor |
BIO-X |
| FB18148 |
191744-13-5 |
BDP 37 |
|
|
BIO-X |
| FB171048 |
86541-75-5 |
Benazepril |
|
|
|
| FB18170 |
19428-14-9 |
Benproperine phosphate |
|
Anti-tussive agent |
|
| FB18200 |
68-90-6 |
Benziodarone |
|
Uricosuric agent |
|
| IC58278 |
90357-06-5 |
Bicalutamide |
|
Androgen receptor antagonist |
|
| FB168813 |
1407495-02-6 |
Bococizumab |
|
|
|
| FB170950 |
1607799-13-2 |
Bremelanotide acetate |
|
|
|
| BB162705 |
76455-48-6 |
4-Bromo-A23187 |
|
Non-fluorescent Ca2+ ionophore; for calibrating fluorescent Ca2+ probes |
|
| FB19345 |
65002-17-7 |
Bucillamine |
|
Potential treatment for gout and rheumatoid arthritis |
|
| FC171039 |
77107-46-1 |
Calmodulin |
|
|
|
| BC162800 |
577696-37-8 |
Cardionogen 1 |
|
Promotes cardiomyocyte generation |
|
| BC164299 |
27724-96-5
34675-84-8 |
Cetraxate hydrochloride |
|
Anti-ulcerative agent |
|
| FC20409 |
94-20-2 |
Chlorpropamide |
|
Hypoglycemic agent |
|
| FC20416 |
95-25-0
202-403-9 |
Chlorzoxazone |
|
Muscle relaxant; treats muscle spasms |
|
| BC164318 |
4291-63-8 |
Cladribine |
|
Deoxyadenosine analog resistant to adenosine deaminase |
BIO-X |
| BC167259 |
130-26-7 |
Clioquinol |
|
Anti-infective agent against diarrhoea; chelating application for Alzheimer’s |
|
| FC161383 |
71923-34-7 |
Clodoxopone |
|
Hypolipidemic agent |
|
| BC166450 |
|
CMP 98 |
|
Negative control for CM11; no effect on VHL E3 ubiquitin ligase |
|
| FC161379 |
4366-18-1 |
Coumetarol |
|
Anti-coagulant |
|
| FA145499 |
125314-13-8 |
CP 21 |
|
|
|
| EC70361 |
6190-45-0 |
Creatine phosphate disodium salt hexahydrate |
|
Phosphate reservoir in muscles, aiding conversion of ADP to ATP |
|
| FC138959 |
172430-48-7 |
CVT 3369 |
|
Metabolite of ranolazine |
|
| FA108700 |
100929-53-1 |
DAMGO |
|
μ-opioid receptor agonist |
|
| FB20882 |
201530-41-8 |
Deferasirox |
|
Tridentate iron chelator |
|
| FD64999 |
554435-83-5 |
Deferasirox Fe3+ Chelate |
|
Iron chelator |
|
| FD21050 |
148-51-6 |
4-Deoxypyridoxine hydrochloride |
|
Vitamin B6 antimetabolite |
|
| BD170166 |
120444-72-6 |
Deramciclane fumarate |
|
Non-benzodiazepine-type anxiolytic drug; used various types of anxiety disorders |
|
| BE162326 |
95-04-5 |
Ectylurea |
|
Sedative; anti-convulsant |
|
| BE168495 |
1270012-79-7 |
Efmoroctocog Alfa |
|
Recombinant antihaemophilic glycoprotein |
BIO-X |
| FE157996 |
488832-69-5 |
Elesclomol |
|
|
BIO-X |
| FD21372 |
54024-22-5 |
13-Ethyl-11-methylene-18,19-dinor-17alpha-pregn-4-en-20-yn-17-ol |
|
|
|
| BE164429 |
7414-83-7 |
Etidronate disodium |
|
Atherosclerotic plaque inhibitor; anti-bone resorptive therapy |
|
| FE65021 |
52479-85-3 |
Exifone |
|
Mildly inhibits tau protein fibril formation; enhances cognitive function |
|
| FD109163 |
38234-21-8 |
Fertirelin |
|
|
|
| BF162803 |
2719-05-3 |
FH 1 |
|
Promotes differentiation of iPSCs into hepatocytes |
|
| NF32352 |
9001-32-5 |
Fibrinogen - from bovine plasma |
|
Required for blood coagulation |
|
| FF35415 |
27072-45-3
3326-32-7 |
Fluorescein isothiocyanate |
|
Labeling reagent for fluorescent-based applications |
|
| BF170770 |
9002-68-0 |
Follicle Stimulating Hormone |
|
|
|
| OF04094 |
114870-03-0 |
Fondaparinux sodium |
|
|
|